INVO Bioscience, Inc. | Business Contracts

Registration Rights Agreement (Filed With SEC on March 23, 2023)

TA Letter dated February 17, 2023 (Filed With SEC on February 23, 2023)

Distribution Agreement with Ming Mei Technology Co. Ltd (Filed With SEC on January 5, 2023)

Lease Agreement (Filed With SEC on May 26, 2022)

JV IP License Agreement (Filed With SEC on June 30, 2021)

Employment Agreement (Filed With SEC on June 15, 2021)

HRCFG INVO LLC limited liability company agreement (Filed With SEC on March 15, 2021)

Joint Venture Agreement (Macedonia) (Filed With SEC on November 25, 2020)

Securities Purchase Agreement (Filed With SEC on March 23, 2023)

Form of Warrant (Filed With SEC on March 23, 2023)

Form of Convertible Promissory Note (Filed With SEC on March 23, 2023)

Membership Interest Purchase Agreement dated March 16, 2023 by and among Wood Violet Fertility LLC, a Delaware limited liability company, Fertility Labs of Wisconsin, LLC, a... (Filed With SEC on March 20, 2023)

Asset Purchase Agreement dated March 16, 2023, by and among Wood Violet Fertility LLC, a Delaware limited liability company, Wisconsin Fertility and Reproductive Surgery... (Filed With SEC on March 20, 2023)

Membership Interest Purchase Agreement dated March 16, 2023 by and among Wood Violet Fertility LLC, a Delaware limited liability company, Fertility Labs of Wisconsin, LLC, a... (Filed With SEC on March 20, 2023)

Asset Purchase Agreement dated March 16, 2023, by and among Wood Violet Fertility LLC, a Delaware limited liability company, Wisconsin Fertility and Reproductive Surgery... (Filed With SEC on March 20, 2023)

Debenture dated February 17, 2023 (Filed With SEC on February 23, 2023)

Warrant dated February 17, 2023 (Filed With SEC on February 23, 2023)

Securities Purchase Agreement dated February 17, 2023 (Debenture and Warrant) (Filed With SEC on February 23, 2023)

Registration Rights Agreement dated February 3, 2023 (Equity Purchase Agreement) (Filed With SEC on February 9, 2023)

Equity Purchase Agreement dated February 3, 2023 (Filed With SEC on February 9, 2023)

TA Letter dated February 3, 2023 (Filed With SEC on February 9, 2023)

Registration Rights Agreement dated February 3, 2023 (Debenture and Warrant) (Filed With SEC on February 9, 2023)

Securities Purchase Agreement dated February 3, 2023 (Debenture and Warrant) (Filed With SEC on February 9, 2023)

Warrant dated December 29, 2022 issued by INVO Bioscience, Inc. in favor of JAG Multi Investments LLC (Filed With SEC on January 5, 2023)

Letter Agreement between INVO Bioscience, Inc. and JAG Multi Investments LLC (Filed With SEC on January 5, 2023)

Demand Promissory Note dated December 29, 2022 issued by INVO Bioscience, Inc. in favor of JAG Multi Investments LLC in the amount of $100,000 (Filed With SEC on January 5, 2023)

Form of Convertible Promissory Note (Filed With SEC on January 5, 2023)

Form of Warrant (Filed With SEC on January 5, 2023)

Securities Purchase Agreement (Filed With SEC on January 5, 2023)

Registration Rights Agreement (Filed With SEC on January 5, 2023)

Demand Promissory Note dated December 13, 2022 issued by INVO Bioscience, Inc. in favor of JAG Multi Investments LLC in the amount of $50,000 (Filed With SEC on December 19, 2022)

Demand Promissory Note dated December 13, 2022 issued by INVO Bioscience, Inc. in favor of Andax LLC in the amount of $25,000 (Filed With SEC on December 19, 2022)

Demand Promissory Note dated December 13, 2022 issued by INVO Bioscience, Inc. in favor of Steven Shum in the amount of $25,000 (Filed With SEC on December 19, 2022)

Demand Promissory Note dated December 2, 2022 issued by INVO Bioscience, Inc. in favor of Steven Shum in the amount of $15,000 (Filed With SEC on December 5, 2022)

Demand Promissory Note dated November 29, 2022 issued by INVO Bioscience, Inc. in favor of Andax LLC in the amount of $75,000 (Filed With SEC on December 5, 2022)

Demand Promissory Note dated November 29, 2022 issued by INVO Bioscience, Inc. in favor of Steven Shum in the amount of $60,000 (Filed With SEC on December 5, 2022)

Form of Demand Note (Filed With SEC on November 14, 2022)

Exclusive Distribution Agreement (Filed With SEC on May 16, 2022)

Termination Notice to Paradigm Opportunities Fund, LP dated March 30, 2022 (Filed With SEC on March 31, 2022)

Termination Notice to Medesole Healthcare and Trading Private Limited dated March 29, 2022 (Filed With SEC on March 31, 2022)

Description of Capital Stock (Filed With SEC on March 31, 2022)

Third Amendment to Stock Purchase Agreement (Filed With SEC on February 2, 2022)

Second Amendment to Stock Purchase Agreement (Filed With SEC on January 6, 2022)

Amendment to Stock Purchase Agreement (Filed With SEC on December 2, 2021)

INVOcell Supply Agreement (Filed With SEC on December 2, 2021)

Termination Notice (Filed With SEC on November 8, 2021)

Form of Placement Agent Warrant to Purchase Common Stock (Filed With SEC on October 5, 2021)

Form of Securities Purchase Agreement, dated October 1, 2021, between the Company and the purchasers party thereto (Filed With SEC on October 5, 2021)

Placement Agent Agreement, dated October 1, 2021, between the Company and the Placement Agent (Filed With SEC on October 5, 2021)

Stock Purchase Agreement (Filed With SEC on October 4, 2021)

Share Purchase Agreement (Filed With SEC on September 7, 2021)

Guarantee of Sublease (Filed With SEC on June 30, 2021)

INVO IP Sublicense Agreement (Filed With SEC on June 30, 2021)

INVOcell Supply Agreement (Filed With SEC on June 30, 2021)

Management Services Agreement (Filed With SEC on June 30, 2021)

LLC Agreement (Filed With SEC on June 30, 2021)

JV Agreement (Filed With SEC on June 30, 2021)

Lease agreement dated March 17, 2021 between INVO Bioscience, Inc, Trustmark National Bank and HRCFG, LLC (Filed With SEC on May 17, 2021)

Partnership Agreement (Filed With SEC on April 13, 2021)

Lease, dated March 2021, with Trustmark National Bank (Filed With SEC on March 30, 2021)

Description of Capital Stock (Filed With SEC on March 30, 2021)

Press Release dated March 15, 2021 (Filed With SEC on March 15, 2021)

Amendment No. 1 to Distribution Agreement (Filed With SEC on March 8, 2021)

Distribution Agreement (Filed With SEC on December 8, 2020)

Joint Venture Agreement (Malaysia) (Filed With SEC on November 25, 2020)

Distribution Agreement (Filed With SEC on November 25, 2020)

Underwriting Agreement, dated November 12, 2020, by and between the Company and Roth Capital Partners, LLC (Filed With SEC on November 13, 2020)

Form of Underwriting Agreement (Filed With SEC on November 9, 2020)

Pre-Incorporation and Shareholders Agreement (Filed With SEC on September 30, 2020)

Form of Underwriting Agreement (Filed With SEC on September 21, 2020)

Securities Purchase Agreement (Filed With SEC on June 26, 2020)

Placement Agent Agreement (Filed With SEC on June 26, 2020)

Form of Unit Purchase Option (Filed With SEC on June 26, 2020)

Form of Secured Convertible Note (Filed With SEC on June 26, 2020)

Form of Registration Rights Agreement (Filed With SEC on May 15, 2020)

Form of Security Agreement (Filed With SEC on May 15, 2020)

Form of Securities Purchase Agreement (Filed With SEC on May 15, 2020)

Form of Warrant (Filed With SEC on May 15, 2020)

Form of Unit Purchase Option (Filed With SEC on May 15, 2020)

Form of Secured Convertible Note (Filed With SEC on May 15, 2020)

Commercial Lease Agreement dated May 1, 2019 between the registrant and PJ LLC (Filed With SEC on March 30, 2020)

Employment Agreement, dated January 15, 2020 (Filed With SEC on January 21, 2020)

Joint Venture Agreement, dated January 13, 2020, between INVO Bioscience, Inc. and Medesole Healthcare and Trading Private Limited, India (Filed With SEC on January 16, 2020)

Agreement for Release of Claims and Stock Option dated October 29, 2019 with James Bowdring (Filed With SEC on November 14, 2019)

Agreement for Release of Claims and Stock Option dated October 29, 2019 with Kathleen Karloff (Filed With SEC on November 14, 2019)

Settlement Agreement and General Release dated November 11, 2019 (Filed With SEC on November 14, 2019)

Employment Offer Letter with Steve Shum (Filed With SEC on October 15, 2019)

Promissory Note August 2016 (Filed With SEC on April 16, 2019)

CONVERTIBLE NOTE PURCHASE AGREEMENT (Filed With SEC on April 16, 2019)

Form of Convertible Note Purchase Agreement 2018 (Filed With SEC on April 16, 2019)

Supply Agreement between the INVO Bioscience, Inc and Ferring International Center S.A (Filed With SEC on April 16, 2019)

Form of Convertible Promissory Note 2018 (Filed With SEC on April 16, 2019)

INVO Bioscience, Inc. (95)